Epidemia COVID-19 epicentro.iss.it2020.
Wu F, Zhao S, Yu B, et al. Complete genome characterization of a novel coronavirus associated with severe human respiratory disease in Wuhan, China. bioRxiv 2020.
Corman VM, Muth D, Niemeyer D, Drosten C. Hosts and sources of endemic human coronaviruses Advances in virus research.
Academic Press 2018; 100: 163-88.
Tang X, Wu C, Li X, et al. On the origin and continuing evolution of SARS-CoV-2. Natl Sci Rev 2020.
Cheng Y, Luo R, Wang K, et al. Kidney impairment is associated with in-hospital death of COVID-19 patients. MedRxiv 2020.
Guan GW, Gao L, Wang JW, et al. Exploring the mechanism of
liver enzyme abnormalities in patients with novel coronavirusinfected
pneumonia Zhonghua gan zang bing za zhi= Zhonghua
ganzangbing zazhi= Chinese journal of hepatology 2020; 28: E002
Fan C, Li K, Ding Y, Lu WL, Wang J. ACE2 expression in kidney and testis may cause kidney and testis damage after 2019-nCoV infection. MedRxiv 2019.
Qian L, Wang R, Qu G, et al. General observation report on the system anatomy of the dead Coronavirus pneumonia. J Forensic Med 2020; 36: 21-3.
Yang Z, Li G, Dai X, Liu G, Li G, Jie Y. Three cases of novel coronavirus pneumonia with viral nucleic acids still positive in stool after throat swab detection turned negative. Chin J Dig 2020; 40: E002-2.
Fang D, Ma J, Guan J, Wang M, Song Y, Tian D. Manifestations of
digestive system in hospitalized patients with novel coronavirus
pneumonia in Wuhan, China: a single-center, descriptive study.
Chin J Dig 2020; 40.
Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther 2020; 51: 843-51.
Marc D, Dominique JF, Élodie B, et al. Human Coronavirus: respiratory pathogens revisited as infectious neuroinvasive, neurotropic, and neurovirulent agents. CRC Press 2013; pp. 93-122.
Li Y, Zhai P, Ding Y. The impact of COVID-19 on ischemic stroke: A case report. Research Square 2020.
Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in critically Ill patients in the Seattle region - Case Series. N Engl J Med 2020.
Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease. Clin Infect Dis 2020.
Cao B, Wang Y, Wen D, et al. A Trial of Lopinavir-Ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 2020.
Yao X, Ye F, Zhang M, et al. In Vitro Antiviral activity and projection of optimized dosing design of Hydroxychloroquine for the treatment of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020.
Multicenter collaboration group of department of science and
technology of Guangdong Province and health commission of
Guangdong Province for chloroquine in the treatment of novel
coronavirus pneumonia Zhonghua Jie He He Hu Xi Za Zhi Chinese
Journal of Tuberculosis and Respiratory Medicine 2020; 43: 185-
Molina JM, Delaugerre C, Le Goff J, et al. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection. Med Mal Infect 2020.
Docherty AB, Harrison EM, Green CA, et al. Features of 16,749
hospitalized UK patients with COVID-19 using the ISARIC WHO
Clinical Characterization Protocol. medRxiv 2020.
Fornari Federico. Vertical transmission of covid-19-A systematic review Journal of pediatrics, perinatology and child health 2020; 4:
Ma S, Gao P, Lu D, Wang G. Prudently conduct the engineering and synthesis of the SARS-CoV-2 virus. Synth Syst Biotechnol 2020.